Sherif Farag

  • 3878 Citations
  • 31 h-Index
1977 …2020
If you made any changes in Pure, your changes will be visible here soon.

Publications 1992 2019

  • 3878 Citations
  • 31 h-Index
  • 85 Article
  • 2 Conference contribution
  • 1 Chapter
  • 1 Review article
2019

Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia

Lobashevsky, A. L., Krueger-Sersen, M., Britton, R. M., Littrell, C. A., Singh, S., Cui, C. P., Kashi, Z., Martin, R. K., Breman, A. M., Vance, G. & Farag, S., Jan 1 2019, In : Human Immunology.

Research output: Contribution to journalArticle

Histocompatibility Testing
Loss of Heterozygosity
Major Histocompatibility Complex
Acute Myeloid Leukemia
Cheek
2018
1 Citation (Scopus)
Germ Cell and Embryonal Neoplasms
Stem Cell Transplantation
Costs and Cost Analysis
Transplants
Length of Stay
2017
6 Citations (Scopus)

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., Jan 1 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

Fetal Blood
Transplantation
Neutrophils
Sitagliptin Phosphate
Transplants
8 Citations (Scopus)
Disease control
Monoclonal antibodies
leukemias
Poisons
Stem cells
16 Citations (Scopus)

Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia

Rosko, A. E., Wang, H. L., de Lima, M., Sandmaier, B., Khoury, H. J., Artz, A., Brammer, J., Bredeson, C., Farag, S., Kharfan-Dabaja, M., Lazarus, H. M., Marks, D. I., Martino Bufarull, R., McGuirk, J., Mohty, M., Nishihori, T., Nivison-Smith, I., Rashidi, A., Ringden, O., Seftel, M. & 3 others, Weisdorf, D., Bachanova, V. & Saber, W., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Allografts
B-Lymphocytes
Confidence Intervals
Survival
2016
8 Citations (Scopus)

Cord Blood Hematopoietic Cell Transplantation

Broxmeyer, H., Farag, S. & Rocha, V., Jan 1 2016, Thomas' Hematopoietic Cell Transplantation: Fifth Edition. Wiley Blackwell, Vol. 1-2. p. 437-455 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cell Transplantation
Fetal Blood
Blood Cells
Transplants
Blood Banks
2 Citations (Scopus)

Killer Cell Immunoglobulin-Like Receptor Ligand Mismatching: To Match or Mismatch?

Farag, S., Feb 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 2, p. 192-194 3 p.

Research output: Contribution to journalArticle

KIR Receptors
Histocompatibility
Natural Killer Cells
Immunoglobulins
Ligands
3 Citations (Scopus)

Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation

Fife, B. L., Von Ah, D., Spath, M. L., Weaver, M. T., Yang, Z., Stump, T. & Farag, S., Nov 21 2016, (Accepted/In press) In : Bone Marrow Transplantation.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
Caregivers
Quality of Life
Publications
Parents
2015

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Khawaja, M. R., Perkins, S., Schwartz, J. E., Robertson, M., Kiel, P. J., Sayar, H., Cox, E. A., Vance, G., Farag, S., Cripe, L. & Nelson, R., Feb 1 2015, In : American Journal of Hematology. 90, 2, p. 97-99 3 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cyclophosphamide
Survival
Recurrence
Disease-Free Survival
10 Citations (Scopus)

The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma

Altenburg, J. D. & Farag, S., Feb 1 2015, In : Expert Opinion on Investigational Drugs. 24, 2, p. 261-271 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Retinoblastoma Protein
Cyclins
Cyclin-Dependent Kinases
palbociclib
2014
24 Citations (Scopus)

A phase I trial of flavopiridol in relapsed multiple myeloma

Hofmeister, C. C., Poi, M., Bowers, M. A., Zhao, W., Phelps, M. A., Benson, D. M., Kraut, E. H., Farag, S., Efebera, Y. A., Sexton, J., Lin, T. S., Grever, M. & Byrd, J. C., 2014, In : Cancer Chemotherapy and Pharmacology. 73, 2, p. 249-257 9 p.

Research output: Contribution to journalArticle

alvocidib
Multiple Myeloma
Pharmacokinetics
Transaminases
Cyclin-Dependent Kinase 9
13 Citations (Scopus)

Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation

Vélez De Mendizábal, N., Strother, R. M., Farag, S., Broxmeyer, H., Messina-Graham, S., Chitnis, S. D. & Bies, R., Mar 2014, In : Clinical Pharmacokinetics. 53, 3, p. 247-259 13 p.

Research output: Contribution to journalArticle

Dipeptidyl Peptidase 4
Cell Transplantation
Hematologic Neoplasms
Fetal Blood
Blood Cells
2013
13 Citations (Scopus)
Cell Transplantation
Fetal Blood
Blood Cells
Economics
Hematopoietic Stem Cells
74 Citations (Scopus)

Differential stem-and progenitor-cell trafficking by prostaglandin e 2

Hoggatt, J., Mohammad, K., Singh, P., Hoggatt, A. F., Chitteti, B. R., Speth, J. M., Hu, P., Poteat, B. A., Stilger, K. N., Ferraro, F., Silberstein, L., Wong, F. K., Farag, S., Czader, M., Milne, G. L., Breyer, R. M., Serezani, C. H., Scadden, D. T., Guise, T., Srour, E. & 1 others, Pelus, L., Mar 21 2013, In : Nature. 495, 7441, p. 365-369 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Prostaglandins
Stem Cells
Prostaglandins E
Receptors, Prostaglandin E, EP2 Subtype
63 Citations (Scopus)

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

Farag, S., Srivastava, S., Messina-Graham, S., Schwartz, J., Robertson, M., Abonour, R., Cornetta, K., Wood, L., Secrest, A., Strother, R. M., Jones, D. R. & Broxmeyer, H., Apr 1 2013, In : Stem Cells and Development. 22, 7, p. 1007-1015 9 p.

Research output: Contribution to journalArticle

Dipeptidyl Peptidase 4
Hematologic Neoplasms
Fetal Blood
Transplants
Stem Cells
2 Citations (Scopus)

Standard pentostatin dose reductions in renal insufficiency are not adequate: Selected patients with steroid-refractory acute graft-versus-host disease

Poi, M. J., Hofmeister, C. C., Johnston, J. S., Edwards, R. B., Jansak, B. S., Lucas, D. M., Farag, S., Dalton, J. T., Devine, S. M., Grever, M. R. & Phelps, M. A., Aug 2013, In : Clinical Pharmacokinetics. 52, 8, p. 705-712 8 p.

Research output: Contribution to journalArticle

Pentostatin
Graft vs Host Disease
Renal Insufficiency
Steroids
Creatinine
15 Citations (Scopus)
Philadelphia Chromosome
Liposomes
Vincristine
Chromosomes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2012
130 Citations (Scopus)

Aphase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., Caligiuri, M. A. & Farag, S., Nov 22 2012, In : Blood. 120, 22, p. 4324-4333 10 p.

Research output: Contribution to journalArticle

KIR Receptors
Multiple Myeloma
Refractory materials
Pharmacodynamics
Pharmacokinetics
112 Citations (Scopus)

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

Broxmeyer, H., Hoggatt, J., O'leary, H. A., Mantel, C., Chitteti, B. R., Cooper, S., Messina-Graham, S., Hangoc, G., Farag, S., Rohrabaugh, S. L., Ou, X., Speth, J., Pelus, L., Srour, E. & Campbell, T. B., Dec 2012, In : Nature Medicine. 18, 12, p. 1786-1796 11 p.

Research output: Contribution to journalArticle

Colony-Stimulating Factors
Hematopoiesis
Chemotherapy
Granulocyte-Macrophage Colony-Stimulating Factor
Stem cells
19 Citations (Scopus)

T Cell-Depleted Partial Matched Unrelated Donor Transplant for Advanced Myeloid Malignancy: KIR Ligand Mismatch and Outcome

Weisdorf, D., Cooley, S., Devine, S., Fehniger, T. A., DiPersio, J., Anasetti, C., Waller, E. K., Porter, D., Farag, S., Drobyski, W., Defor, T., Haagenson, M., Curtsinger, J. & Miller, J., Jun 2012, In : Biology of Blood and Marrow Transplantation. 18, 6, p. 937-943 7 p.

Research output: Contribution to journalArticle

Unrelated Donors
Ligands
T-Lymphocytes
Transplants
Confidence Intervals
2011
6 Citations (Scopus)

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. & Farag, S., Jul 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Etoposide
Non-Hodgkin's Lymphoma
Cyclophosphamide
Maximum Tolerated Dose
1 Citation (Scopus)

Aurora kinase A inhibitor protein kinase inhibitor oncolytic

Zhang, S. & Farag, S., 2011, In : Drugs of the Future. 36, 1, p. 5-15 11 p.

Research output: Contribution to journalArticle

Aurora Kinase A
Protein Kinase Inhibitors
Multiple Myeloma
Protein-Tyrosine Kinases
Aurora Kinase B
73 Citations (Scopus)

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission

Farag, S., Maharry, K., Zhang, M. J., Pérez, W. S., George, S. L., Mrózek, K., DiPersio, J., Bunjes, D. W., Marcucci, G., Baer, M. R., Cairo, M., Copelan, E., Cutler, C. S., Isola, L., Lazarus, H. M., Litzow, M. R., Marks, D. I., Ringdén, O., Rizzieri, D. A., Soiffer, R. & 4 others, Larson, R. A., Tallman, M. S., Bloomfield, C. D. & Weisdorf, D. J., Dec 2011, In : Biology of Blood and Marrow Transplantation. 17, 12, p. 1796-1803 8 p.

Research output: Contribution to journalArticle

Cell Transplantation
Acute Myeloid Leukemia
Drug Therapy
Leukemia
Survival
4 Citations (Scopus)

From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

Zhang, S. & Farag, S., Jul 2011, In : Expert Opinion on Investigational Drugs. 20, 7, p. 1015-1028 14 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cell Biology
Therapeutics
ENMD 2076
Expert Testimony
1 Citation (Scopus)
Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Non-Hodgkin's Lymphoma
Hematopoietic Stem Cells
110 Citations (Scopus)

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Benson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., Hofmeister, C. C., Efebera, Y., Andre, P., Romagne, F., Bléry, M., Bonnafous, C., Zhang, J., Clever, D., Caligiuri, M. A. & Farag, S., Dec 8 2011, In : Blood. 118, 24, p. 6387-6391 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Natural Killer Cells
Natural Killer Cell Receptors
Ligands
Antibodies
27 Citations (Scopus)

Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.

Farag, S., Wood, L. L., Schwartz, J. E., Srivastava, S., Nelson, R., Robertson, M., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K. & Jones, D. R., Apr 2011, In : Leukemia. 25, 4, p. 599-605 7 p.

Research output: Contribution to journalArticle

Busulfan
Stem Cell Transplantation
Leukemia
Pharmacokinetics
Maximum Tolerated Dose
59 Citations (Scopus)

Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: Evidence for lenalidomide-CCI-779 interaction via P-glycoprotein

Hofmeister, C. C., Yang, X., Pichiorri, F., Chen, P., Rozewski, D. M., Johnson, A. J., Lee, S., Liu, Z., Garr, C. L., Hade, E. M., Ji, J., Schaaf, L. J., Benson, D. M., Kraut, E. H., Hicks, W. J., Chan, K. K., Chen, C. S., Farag, S., Grever, M. R., Byrd, J. C. & 1 others, Phelps, M. A., Sep 1 2011, In : Journal of Clinical Oncology. 29, 25, p. 3427-3434 8 p.

Research output: Contribution to journalArticle

P-Glycoprotein
Multiple Myeloma
Pharmacokinetics
Maximum Tolerated Dose
Drug Interactions
22 Citations (Scopus)

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation

Rosenbeck, L. L., Kiel, P. J., Kalsekar, I., Vargo, C., Baute, J., Sullivan, C. K., Wood, L., Abdelqader, S., Schwartz, J., Srivastava, S., Abonour, R., Robertson, M., Nelson, R., Cornetta, K., Fausel, C. A. & Farag, S., Jun 2011, In : Biology of Blood and Marrow Transplantation. 17, 6, p. 916-922 7 p.

Research output: Contribution to journalArticle

Antilymphocyte Serum
Stem Cell Transplantation
Tacrolimus
Graft vs Host Disease
Sirolimus
48 Citations (Scopus)

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901

Shea, T., Johnson, J., Westervelt, P., Farag, S., McCarty, J., Bashey, A., Isola, L., Baxter-Lowe, L. A., Kelly, M., Owzar, K. & Linker, C., Sep 2011, In : Biology of Blood and Marrow Transplantation. 17, 9, p. 1395-1403 9 p.

Research output: Contribution to journalArticle

Homologous Transplantation
Disease-Free Survival
B-Lymphocytes
Neoplasms
B-Cell Chronic Lymphocytic Leukemia
7 Citations (Scopus)

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)

Bashey, A., Owzar, K., Johnson, J. L., Edwards, P. S., Kelly, M., Baxter-Lowe, L. A., Devine, S., Farag, S., Hurd, D., Ball, E., McCarthy, P., Lister, J., Shea, T. C. & Linker, C., Apr 2011, In : Biology of Blood and Marrow Transplantation. 17, 4, p. 558-565 8 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Cell Transplantation
Hematologic Neoplasms
Unrelated Donors
Leukemia
28 Citations (Scopus)

The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells

Zhang, S., Suvannasankha, A., Crean, C. D., White, V. L., Chen, C. S. & Farag, S., Jul 1 2011, In : International Journal of Cancer. 129, 1, p. 204-213 10 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Cell Cycle Checkpoints
Multiple Myeloma
Apoptosis
Cyclin D1
39 Citations (Scopus)

The potential role of Aurora kinase inhibitors in haematological malignancies

Farag, S., Dec 2011, In : British Journal of Haematology. 155, 5, p. 561-579 19 p.

Research output: Contribution to journalArticle

Aurora Kinases
Hematologic Neoplasms
Neoplasms
Cytotoxins
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2010
13 Citations (Scopus)

Long-term disease-free survival after nonmyeloablative cyclophosphamide/ fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia

Nelson, R., Yu, M., Schwartz, J. E., Robertson, M., Hromas, R., Fausel, C. A., Vance, G., Dlouhy, S., Baute, J. A., Cox, E. A., Wood, L. L., Srivastava, S., Robertson, K., Haut, P., Farag, S., Abonour, R., Cornetta, K. & Cripe, L., Aug 2010, In : Bone Marrow Transplantation. 45, 8, p. 1300-1308 9 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cyclophosphamide
Disease-Free Survival
Unrelated Donors
Survivors
26 Citations (Scopus)

Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma

Wang, X., Sinn, A. L., Pollok, K., Sandusky, G., Zhang, S., Chen, L., Liang, J., Crean, C. D., Suvannasankha, A., Abonour, R., Sidor, C., Bray, M. R. & Farag, S., Aug 2010, In : British Journal of Haematology. 150, 3, p. 313-325 13 p.

Research output: Contribution to journalArticle

Aurora Kinases
Multiple Myeloma
Protein-Tyrosine Kinases
Aurora Kinase B
Aurora Kinase A
25 Citations (Scopus)

Quantification of non-specific binding of magnetic micro- and nanoparticles using cell tracking velocimetry: Implication for magnetic cell separation and detection

Chalmers, J. J., Xiong, Y., Jin, X., Shao, M., Tong, X., Farag, S. & Zborowski, M., Apr 15 2010, In : Biotechnology and Bioengineering. 105, 6, p. 1078-1093 16 p.

Research output: Contribution to journalArticle

Cell Tracking
Rheology
Cell Separation
Velocity measurement
Nanoparticles
2009
2 Citations (Scopus)

Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation

Ruggeri, L., Zhang, S. & Farag, S., 2009, In : Cancer Treatment and Research. 144, p. 47-69 23 p.

Research output: Contribution to journalArticle

KIR Receptors
Biological Models
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
HLA Antigens
64 Citations (Scopus)

Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma

Farag, S., Zhang, S., Jansak, B. S., Wang, X., Kraut, E., Chan, K., Dancey, J. E. & Grever, M. R., Nov 2009, In : Leukemia Research. 33, 11, p. 1475-1480 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Appointments and Schedules
70-kDa Ribosomal Protein S6 Kinases
Stomatitis
Interstitial Lung Diseases
2008
39 Citations (Scopus)

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation

Hamadani, M., Hofmeister, C. C., Jansak, B., Phillips, G., Elder, P., Blum, W., Penza, S., Lin, T. S., Klisovic, R., Marcucci, G., Farag, S. & Devine, S. M., Jul 2008, In : Biology of Blood and Marrow Transplantation. 14, 7, p. 783-789 7 p.

Research output: Contribution to journalArticle

Cell Transplantation
Graft vs Host Disease
Blood Cells
Control Groups
Unrelated Donors
27 Citations (Scopus)

Antimyeloma effects of a sesquiterpene lactone parthenolide

Suvannasankha, A., Crean, C. D., Shanmugam, R., Farag, S., Abonour, R., Boswell, H. & Nakshatri, H., Mar 15 2008, In : Clinical Cancer Research. 14, 6, p. 1814-1822 9 p.

Research output: Contribution to journalArticle

Sesquiterpenes
Lactones
Multiple Myeloma
Caspases
Mesenchymal Stromal Cells
11 Citations (Scopus)

Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma

Hofmeister, C. C., Jansak, B., Denlinger, N., Kraut, E. H., Benson, D. M. & Farag, S., Aug 2008, In : Leukemia Research. 32, 8, p. 1295-1298 4 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Vincristine
Multiple Myeloma
Dexamethasone
Hypocalcemia
2007
20 Citations (Scopus)

A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation

Tong, X., Xiong, Y., Zborowski, M., Farag, S. & Chalmers, J. J., Oct 2007, In : Experimental Hematology. 35, 10, p. 1613-1622 10 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
T-Lymphocytes
Blood Buffy Coat
Immunomagnetic Separation
Hematopoietic Stem Cell Transplantation
78 Citations (Scopus)

Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

Jing, Y., Moore, L. R., Williams, P. S., Chalmers, J. J., Farag, S., Bolwell, B. & Zborowski, M., Apr 15 2007, In : Biotechnology and Bioengineering. 96, 6, p. 1139-1154 16 p.

Research output: Contribution to journalArticle

Leukapheresis
Cell Separation
Nanoparticles
Labeling
Blood Cells
20 Citations (Scopus)

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Benson, D. M., Elder, P. J., Lin, T. S., Blum, W., Penza, S., Avalos, B., Copelan, E. & Farag, S., Aug 2007, In : Leukemia Research. 31, 8, p. 1077-1083 7 p.

Research output: Contribution to journalArticle

Busulfan
Melphalan
Stem Cell Transplantation
Etoposide
Multiple Myeloma
203 Citations (Scopus)

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

Miller, J. S., Cooley, S., Parham, P., Farag, S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E. A., Haagenson, M., Horowitz, M. M., Klein, J. P. & Weisdorf, D. J., Jun 1 2007, In : Blood. 109, 11, p. 5058-5061 4 p.

Research output: Contribution to journalArticle

Unrelated Donors
Cell Transplantation
Graft vs Host Disease
Grafts
Natural Killer Cells
31 Citations (Scopus)

Multiple myeloma: Clinical practice guidelines in oncology™

Anderson, K. C., Alsina, M., Bensinger, W., Biermann, J. S., Chanan-Khan, A., Comenzo, R. L., De Castro, C. M., Djulbegovic, B., Farag, S., Huff, C. A., Meredith, R., Schriber, J., Shrieve, D., Singhal, S., Smith, M. R., Stockerl-Goldstein, K., Vose, J. M., Weber, D., Yahalom, J. & Yunus, F., Feb 2007, In : JNCCN Journal of the National Comprehensive Cancer Network. 5, 2, p. 118-147 30 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Practice Guidelines
Therapeutics
Clinical Protocols
Radiotherapy
19 Citations (Scopus)

Negative selection of hematopoietic progenitor cells by continuous magnetophoresis

Jing, Y., Moore, L. R., Schneider, T., Williams, P. S., Chalmers, J. J., Farag, S., Bolwell, B. & Zborowski, M., Apr 2007, In : Experimental Hematology. 35, 4, p. 662-672 11 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Leukapheresis
Stem Cells
Antibodies
Colloids
43 Citations (Scopus)

OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms

Zhang, S., Suvannasankha, A., Crean, C. D., White, V. L., Johnson, A., Chen, C. S. & Farag, S., Aug 15 2007, In : Clinical Cancer Research. 13, 16, p. 4750-4758 9 p.

Research output: Contribution to journalArticle

Celecoxib
Multiple Myeloma
STAT3 Transcription Factor
Apoptosis
Caspases
2006
26 Citations (Scopus)

Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

Lara, O., Tong, X., Zborowski, M., Farag, S. & Chalmers, J. J., May 5 2006, In : Biotechnology and Bioengineering. 94, 1, p. 66-80 15 p.

Research output: Contribution to journalArticle

Immunomagnetic Separation
T-cells
Blood
Technology
T-Lymphocytes
14 Citations (Scopus)

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation

Blum, W., Bolwell, B. J., Phillips, G., Farag, S., Lin, T. S., Avalos, B. R., Penza, S. L., Marcucci, G., Byrd, J. C., Kalaycio, M. E., Sobecks, R. M., Pohlman, B., Brown, S., Elder, P. J. & Copelan, E. A., Jan 2006, In : Biology of Blood and Marrow Transplantation. 12, 1, p. 61-67 7 p.

Research output: Contribution to journalArticle

Unrelated Donors
Cell Transplantation
Acute Myeloid Leukemia
Busulfan
Cyclophosphamide